定安县体检人群脂肪肝发生现状及影响因素

doi:10.12183/j.scjpm.2022.1017

[1] Sung KC,Lee MY,Kim YH,et al.Obesity and incidence of diabetes: Effect of absence of metabolic syndrome, insulin resistance,inflammation and fatty liver[J].Atherosclerosis,2018,275:50-57.
[2] 余双彬,俞梦璐,陈曦,等.四川省绵阳市成人脂肪肝流行现况及其代谢异常情况分析[J].中国医学科学院学报,2019,41(3):323-330.
[3] Araújo AR,Rosso N,Bedogni G,et al.Global epidemiology of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis:What we need in the future[J].Liver Int,2018,38(Suppl 1):47-51.
[4] 邓江,拓宽前,李建宁,等.脂肪肝患者发生空腹血糖升高的风险:一项40 381人近10年的队列研究[J].中华肝脏病杂志,2021,29(5):446-450.
[5] 朱海建,洪峰,关菡,等.贵州省黔东南州侗族成年人脂肪肝流行现况及其影响因素分析[J].现代预防医学,2020,47(10):1742-1745.
[6] Tokushige K,Ikejima K,Ono M, et al.Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis 2020[J].J Gastroenterol,2021,56(11):951-963.
[7] 中华医学会健康管理学分会,中国营养学会,中国医疗保健国际交流促进会生殖医学分会,等.超重或肥胖人群体重管理专家共识及团体标准[J].中华健康管理学杂志,2018,12(3):200-207.
[8] 中国成人血脂异常防治指南修订联合委员会.中国成人血脂异常防治指南(2016年修订版)[J].中华全科医师杂志,2017,16(1):15-35.
[9] Borghi C,Domienik-Karłowicz J,Tykarski A,et al.Expert consensus for the diagnosis and treatment of patient with hyperuricemia and high cardiovascular risk:2021 update[J].Cardiol J,2021,28(1):1-14.
[10] 中国老年医学学会,中国老年医学学会高血压分会,中国老年医学学会认知障碍分会,等.老年高血压合并认知障碍诊疗中国专家共识(2021版)[J].中国心血管杂志,2021,26(2):101-111.
[11] 中国医师协会内分泌代谢科医师分会,国家代谢性疾病临床医学研究中心.糖尿病分型诊断中国专家共识[J].中华糖尿病杂志,2022,14(2):120-139.
[12] 中华医学会骨质疏松和骨矿盐疾病分会.维生素D及其类似物临床应用共识[J].中华骨质疏松和骨矿盐疾病杂志,2018,11(1):1-19.
[13] 黄向阳. 2015—2016年梅州市体检人群脂肪肝患病率及流行病学特点分析[J].中国预防医学杂志,2018,19(5):395-397.
[14] 余纪会,唐兰,赵文苹,等.重庆地区体检人群脂肪肝与其他常见代谢性疾病患病情况及相关性分析[J].公共卫生与预防医学,2019,30(3):87-90.
[15] 何帆,黎文军,马觉民.柳州市健康体检人群糖脂代谢、体质量指数异常与脂肪肝发病率的关系[J].贵州医药,2018,42(9):1129-1131.
[16] Eddowes PJ,McDonald N,Davies N,et al.Utility and cost evaluation of multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease[J].Aliment Pharmacol Ther,2018,47(5):631-644.
[17] Munsterman ID, Kendall TJ, Khelil N, et al.Extracellular matrix components indicate remodelling activity in different fibrosis stages of human non-alcoholic fatty liver disease[J].Histopathology,2018,73(4):612-621.
[18] Wang J,Chiu WH,Chen RC,et al.The clinical investigation of disparity of nonalcoholic fatty liver disease in a Chinese occupational population in Taipei,Taiwan: Experience at a teaching hospital[J].Asia Pac J Public Health,2015,27(2):NP1793-804.
[19] 王诗钰,史琴瑶,陈柳,等.2型糖尿病合并脂肪肝老年患者胰岛素抵抗及脂代谢状况分析[J].解放军预防医学杂志,2018,36(8):993-995,999.
[20] 章雅南,刘奕婷.沈阳市健康体检人群非酒精性脂肪肝患病情况及影响因素[J].公共卫生与预防医学,2019,30(3):67-70.
[21] 孙海燕. 非酒精性脂肪肝患者血生化指标、饮食及行为特征研究[J].华南预防医学,2020,46(6):605-608.
[22] 潘晓芳,吴静标,黄燕虹,等.我国25-羟基维生素D检测方法及其研究进展[J].分子诊断与治疗杂志,2020,12(12):1591-1595,1584.
[23] Wang X,Li W,Zhang Y,et al.Association between vitamin D and non-alcoholic fatty liver disease/non-alcoholic steatohepatitis: Results from a meta-analysis[J].Int J Clin Exp Med,2015,8(10):17221-17234.

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Metrics

Comments

Recommended 0

[1]	YAN Chun, GONG Yuan, HUANG Ping, CHEN Juan, HUANG Miao. Early poor prognosis and predictive model construction in patients with acute ischemic stroke [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1213-1217.
[2]	XU Yan, WANG Xuexia, HAN Chunling. Characteristics and influencing factors of polypoid lesion of gallbladder in adult residents of Dongying City [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1224-1228.
[3]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1294-1297.
[4]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1305-1308.
[5]	. [J]. South China Journal of Preventive Medicine, 2023, 49(10): 1327-1329.
[6]	JING Leilei, WANG Yating, YANG Yong, LI Yajie, ZHAO Haiying, LI Huifang, LI Zhanpeng. Influencing factors of knee osteoarthritis in people ≥ 40 years old in Zhangjiakou area [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1078-1082.
[7]	WANG Shijian, CHEN Zelun, ZHENG Jingjing, XU Ying. Analysis of the incidence and influencing factors of retinopathy in elderly patients with hypertension [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1098-1102.
[8]	ZHAO Xiaohong, XU Shanshan, HAN Yuzhou, HUANG Haisha, SUN Jingjing. Status and influencing factors of adverse pregnancy outcomes in pregnant women with gestational diabetes mellitus in Langfang City [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1109-1113.
[9]	LI Nannan, HUANG Limin, ZHANG Xiaohua. Incidence and risk factors of major adverse cardiovascular events in patients with acute coronary syndrome within 1 year after discharge [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1119-1123.
[10]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1180-1183.
[11]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1188-1191.
[12]	. [J]. South China Journal of Preventive Medicine, 2023, 49(9): 1205-1208.
[13]	YAN Yongfeng, XU Yuanyou, WANG Jun, CHEN Yongsheng, ZHANG Yonghui, DING Lulu, CHEN Jianguo, FAN Jian, ZHU Jian. Trend analysis of brain tumor survival rate in Qidong City, Jiangsu Province, 1972 - 2016 [J]. South China Journal of Preventive Medicine, 2023, 49(8): 960-964.
[14]	LUO Chengli, LIU Fangjing, PENG Xiang, LI Shimei, WU Qiaohui, MAO Li, DONG Yuan, SUN Xianfu, LI Shuangle. Prevalence and influencing factors of cataract among the elderly in Zigong City [J]. South China Journal of Preventive Medicine, 2023, 49(8): 990-994.
[15]	FAN Hailong, NIU Yanbin, GUO Zhenshan, AN Qianjiang, WANG Xiumei. Association between visceral adiposity index and blood glucose variation in Chinese middle-aged and elderly prediabetic population： a cohort study [J]. South China Journal of Preventive Medicine, 2023, 49(7): 803-807.